Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Prashant Tibrewal

Showing results (41-50 of 59) with videos related to

Pageof 6
Sort By:
The Australian and New Zealand Journal of Psychiatry|July 9, 2016
Parenteral lorazepam's unavailability in Australia and the impact for catatonic patientsDavid Alvin Low, Jennifer Xu, Prashant Tibrewal, et al.
The Australian and New Zealand Journal of Psychiatry|August 20, 2016
Delusion of pregnancy - Is there a role of prolactin?Alice Gillian Keane, Tarun Bastiampillai, Rohan Dhillon, et al.
Asian Journal of Psychiatry|August 9, 2017
Folie à deux and Delusional ParasitosisAndrew Giam, Yan Lam Tung, Prashant Tibrewal, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|September 1, 2010
Response rate of lorazepam in catatonia: a developing country's perspectivePrashant Tibrewal, Janardhanan Narayanaswamy, Amit Zutshi, et al.
The Primary Care Companion for CNS Disorders|January 20, 2017
Aripiprazole and Impulse-Control Disorders: A Recent FDA Warning and a Case ReportRohan Dhillon, Tarun Bastiampillai, Claudia Z Cao, et al.
The Primary Care Companion for CNS Disorders|July 7, 2017
Lurasidone-Induced DystoniaPrashant Tibrewal, Rachel Cheng, Tarun Bastiampillai, et al.
Asian Journal of Psychiatry|March 4, 2015
Central pontine myelinolysis-induced mania: A case studyRachel Goggin, Nicholas Nguyen, Prashant Tibrewal, et al.
The Australian and New Zealand Journal of Psychiatry|August 26, 2015
Is electroconvulsive therapy safe in multiple sclerosis?Truc Tran, Prashant Tibrewal, Rohan Dhillon, et al.
General Hospital Psychiatry|March 6, 2012
Clinical predictors of response to treatment in catatoniaJanardhanan C Narayanaswamy, Prashant Tibrewal, Amit Zutshi, et al.
The Australian and New Zealand Journal of Psychiatry|March 19, 2022
The evidence for the use of long-term benzodiazepines in the setting of treatment-refractory anxiety disordersPrashant Tibrewal, Milanduth K Kanigere, Jeffrey Cl Looi, et al.
Pageof 6

Showing results (41-50 of 59) with videos related to

Sort By:
Pageof 6
The Australian and New Zealand Journal of Psychiatry|July 9, 2016
Parenteral lorazepam's unavailability in Australia and the impact for catatonic patientsDavid Alvin Low, Jennifer Xu, Prashant Tibrewal, et al.
The Australian and New Zealand Journal of Psychiatry|August 20, 2016
Delusion of pregnancy - Is there a role of prolactin?Alice Gillian Keane, Tarun Bastiampillai, Rohan Dhillon, et al.
Asian Journal of Psychiatry|August 9, 2017
Folie à deux and Delusional ParasitosisAndrew Giam, Yan Lam Tung, Prashant Tibrewal, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|September 1, 2010
Response rate of lorazepam in catatonia: a developing country's perspectivePrashant Tibrewal, Janardhanan Narayanaswamy, Amit Zutshi, et al.
The Primary Care Companion for CNS Disorders|January 20, 2017
Aripiprazole and Impulse-Control Disorders: A Recent FDA Warning and a Case ReportRohan Dhillon, Tarun Bastiampillai, Claudia Z Cao, et al.
The Primary Care Companion for CNS Disorders|July 7, 2017
Lurasidone-Induced DystoniaPrashant Tibrewal, Rachel Cheng, Tarun Bastiampillai, et al.
Asian Journal of Psychiatry|March 4, 2015
Central pontine myelinolysis-induced mania: A case studyRachel Goggin, Nicholas Nguyen, Prashant Tibrewal, et al.
The Australian and New Zealand Journal of Psychiatry|August 26, 2015
Is electroconvulsive therapy safe in multiple sclerosis?Truc Tran, Prashant Tibrewal, Rohan Dhillon, et al.
General Hospital Psychiatry|March 6, 2012
Clinical predictors of response to treatment in catatoniaJanardhanan C Narayanaswamy, Prashant Tibrewal, Amit Zutshi, et al.
The Australian and New Zealand Journal of Psychiatry|March 19, 2022
The evidence for the use of long-term benzodiazepines in the setting of treatment-refractory anxiety disordersPrashant Tibrewal, Milanduth K Kanigere, Jeffrey Cl Looi, et al.
Pageof 6